Nuvectis Pharma, Inc. (NVCT)
NASDAQ: NVCT · IEX Real-Time Price · USD
7.00
+0.55 (8.53%)
Jun 20, 2024, 2:01 PM EDT - Market open

Nuvectis Pharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year
Current20232022
Market Capitalization
128145110
Market Cap Growth
-31.58%-
Enterprise Value
9912590
PE Ratio
-6.51-6.49-5.75
PB Ratio
8.4411.847.72
P/FCF Ratio
-9.38-9.06-8.10
P/OCF Ratio
-9.38-9.06-8.10
EV/EBITDA Ratio
-5.64-5.63-4.71
EV/EBIT Ratio
-5.64-5.63-4.71
EV/FCF Ratio
-8.13-7.86-6.62
Quick Ratio
3.422.743.23
Current Ratio
3.462.753.30
Return on Equity (ROE)
-141.60%-144.80%-125.90%
Return on Assets (ROA)
-104.00%-107.80%-99.00%
Return on Capital (ROIC)
-165.40%-187.66%-135.27%
Earnings Yield
-18.90%-15.40%-17.38%
FCF Yield
-13.12%-11.04%-12.35%
Buyback Yield / Dilution
-12.46%-22.90%-196.55%
Total Shareholder Return
-12.46%-22.90%-196.55%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).